The only direct, swift and accurate way to measure total blood volume and red blood cell volume in the clinical setting

Read More

Key Features

  • Actionable results with 98% accuracy
  • Quantifies the excess or deficit vs patient-specific ideal
  • Non-invasive, single-venipuncture technique

Latest News

Two New Studies from the Mayo Clinic and Lankenau Medical Center Presented at Heart Failure Society of America 2016 Highlight Unique Ability of BVA to Identify High Risk at Discharge in Hospitalized Heart Failure Patients

New York, NY September 29, 2016 – Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, announces two new studies presented at the Heart Failure Society of America meeting this month highlighting risks for hospitalized heart failure patients detectable by direct blood volume measurement (Daxor BVA-100). Michael Feldschuh, President and […]

Read More

Daxor Corporation Announces Hiring of Chief Financial Officer

New York, NY June 17, 2016 – Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, announces the hiring of Eric P. Coleman as its new Chief Financial Officer effective June 6, 2016, reporting directly to Michael Feldschuh, Acting President & CEO of Daxor Corporation. “Mr. Coleman will be responsible […]

Read More